Skip to main content

Advertisement

Log in

Antisense-mediated redirection of mRNA splicing

  • Multi-author Review
  • Published:
Cellular and Molecular Life Sciences CMLS Aims and scope Submit manuscript

Abstract:

Antisense technology has been used to study basic biological processes, and to block these processes when they deleteriously lead to human disease. A separate, equally important application of antisense technology is to upregulate the gene expression lost in the diseased state by shifting alternative splicing of pre-messenger RNA. This strategy has commonly relied upon the use of antisense oligonucleotides; however, another approach is to use a plasmid construct to generate antisense RNA inside the cell. Antisense therapeutics based on expression vectors and viral vectors offers a gene therapy approach, whereas those based on oligonucleotides offers a more drug like approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

RID="*"

ID="*"Corresponding author.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vacek, M., Sazani, P. & Kole, R. Antisense-mediated redirection of mRNA splicing. CMLS, Cell. Mol. Life Sci. 60, 825–833 (2003). https://doi.org/10.1007/s00018-003-3042-7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00018-003-3042-7

Navigation